Skip to main content
. Author manuscript; available in PMC: 2007 Aug 29.
Published in final edited form as: J Bone Miner Res. 2007 Jan;22(1):29–36. doi: 10.1359/JBMR.060914

FIG. 4.

FIG. 4.

A dominant negative mutant PKR increases cell survival in 2-ME–treated cultures of osteosarcoma cells. MG63 cells were transfected with the plasmid pcDNA3-PKR-K296R or empty vector pcDNAneo and treated with vehicle (Veh) or 5 µM 2-ME for 72 h. The cells were harvested, and the viable cell counts were taken after staining with trypan blue. Values are mean ± SE (N = 3 replicate cultures). *p ≤ 0.05 vs. Veh.